Publication: Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network
Issued Date
2020-03-01
Resource Type
ISSN
17517176
15246175
15246175
Other identifier(s)
2-s2.0-85075755592
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Hypertension. Vol.22, No.3 (2020), 331-343
Suggested Citation
Kazuomi Kario, Yook Chin Chia, Apichard Sukonthasarn, Yuda Turana, Jinho Shin, Chen Huan Chen, Peera Buranakitjaroen, Jennifer Nailes, Satoshi Hoshide, Saulat Siddique, Jorge Sison, Arieska Ann Soenarta, Guru Prasad Sogunuru, Jam Chin Tay, Boon Wee Teo, Yu Qing Zhang, Sungha Park, Huynh Van Minh, Naoko Tomitani, Tomoyuki Kabutoya, Narsingh Verma, Tzung Dau Wang, Ji Guang Wang Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network. Journal of Clinical Hypertension. Vol.22, No.3 (2020), 331-343. doi:10.1111/jch.13733 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54626
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network
Author(s)
Kazuomi Kario
Yook Chin Chia
Apichard Sukonthasarn
Yuda Turana
Jinho Shin
Chen Huan Chen
Peera Buranakitjaroen
Jennifer Nailes
Satoshi Hoshide
Saulat Siddique
Jorge Sison
Arieska Ann Soenarta
Guru Prasad Sogunuru
Jam Chin Tay
Boon Wee Teo
Yu Qing Zhang
Sungha Park
Huynh Van Minh
Naoko Tomitani
Tomoyuki Kabutoya
Narsingh Verma
Tzung Dau Wang
Ji Guang Wang
Yook Chin Chia
Apichard Sukonthasarn
Yuda Turana
Jinho Shin
Chen Huan Chen
Peera Buranakitjaroen
Jennifer Nailes
Satoshi Hoshide
Saulat Siddique
Jorge Sison
Arieska Ann Soenarta
Guru Prasad Sogunuru
Jam Chin Tay
Boon Wee Teo
Yu Qing Zhang
Sungha Park
Huynh Van Minh
Naoko Tomitani
Tomoyuki Kabutoya
Narsingh Verma
Tzung Dau Wang
Ji Guang Wang
Other Contributor(s)
University Medicine and Pharmacy, Hue University
De La Salle Health Sciences Institute
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
Fatima Memorial Hospital
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
University of Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Yong Loo Lin School of Medicine
National Taiwan University College of Medicine
King George's Medical University
Faculty of Medicine, Siriraj Hospital, Mahidol University
Tan Tock Seng Hospital
Chiang Mai University
De La Salle Health Sciences Institute
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
Fatima Memorial Hospital
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
University of Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Yong Loo Lin School of Medicine
National Taiwan University College of Medicine
King George's Medical University
Faculty of Medicine, Siriraj Hospital, Mahidol University
Tan Tock Seng Hospital
Chiang Mai University
Abstract
© 2019 Wiley Periodicals, Inc. The Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network was set up to improve the management of hypertension in Asia with the ultimate goal of achieving “zero” cardiovascular events. Asia is a diverse continent, and the prevalence of hypertension has increased over the last 30 years. There are a number of Asia-specific features of hypertension and hypertension-related cardiovascular complications, which means that a region-specific approach is needed. White-coat hypertension will become more of an issue over time as Asian populations age, and masked hypertension is more prevalent in Asian than in Western countries. Identifying and treating masked hypertension is important to reduce cardiovascular risk. Abnormal patterns of blood pressure (BP) variability common in Asia include exaggerated early morning BP surge and nocturnal hypertension. These are also important cardiovascular risk factors that need to be managed. Home blood pressure monitoring (HBPM) is an important tool for detecting white-coat and masked hypertension, and monitoring BP variability, and practices in Asia are variable. Use of HBPM is important given the Asia-specific features of hypertension, and strategies are needed to improve and standardize HBPM usage. Development of HBPM devices capable of measuring nocturnal BP along with other information and communication technology-based strategies are key developments in the widespread implementation of anticipation medicine strategies to detect and prevent cardiovascular events in patients with hypertension. Region-wide differences in hypertension prevalence, control, and management practices in Asia highlight the importance of information sharing to facilitate best practices.